Medications for Cardiomyopathy Due to Anthracyclines
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cardiomyopathy Due to Anthracyclines.
Found 1 Approved Drug for Cardiomyopathy Due to Anthracyclines
Dexrazoxane
Generic Name
Dexrazoxane
Dexrazoxane
Generic Name
Dexrazoxane
Form: Injection, Kit
Method of administration: Intravenous
FDA approval date: March 31, 2005
Classification: Cytoprotective Agent
Dexrazoxane for Injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg /m 2 and who will continue to receive doxorubicin therapy to maintain tumor control. Do not use with the initiation of doxorubicin therapy [see Warnings and Precautions.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances